HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Anti-Asthmatic Agents (Antiasthmatic Drugs)

Subscribe to New Research on Anti-Asthmatic Agents

Drugs that are used to treat asthma.

Also Known As:

Antiasthmatic Drugs; Anti-Asthmatic Drugs; Anti-Asthmatics; Antiasthmatic Agents; Antiasthmatics; Agents, Anti-Asthmatic; Agents, Antiasthmatic; Anti Asthmatic Agents; Anti Asthmatic Drugs; Anti Asthmatics; Drugs, Anti-Asthmatic; Drugs, Antiasthmatic

Networked: 116 relevant articles (3 outcomes, 12 trials/studies) for this Bio-Agent, Comments

Relationship Network

Bio-Agent Context: Research Results

Chemical Actions and Uses
- Pharmacologic Actions: 46
  - Therapeutic Uses: 198
    - Respiratory System Agents: 31
      - Anti-Asthmatic Agents: 116
        Bronchodilator Agents: 1479

Experts

1.	Källén, Bengt: 4 articles (04/2007 - 01/2007)
2.	Otterblad Olausson, Petra: 3 articles (04/2007 - 04/2007)
3.	Bonini, S: 2 articles (04/2009 - 08/2008)
4.	Canonica, G W: 2 articles (08/2008 - 04/2008)
5.	Ito, Kazuhiro: 2 articles (02/2008 - 09/2004)
6.	Caramori, Gaetano: 2 articles (02/2008 - 09/2004)
7.	Adcock, Ian M: 2 articles (02/2008 - 09/2004)
8.	Ventura, M T: 1 article (04/2009)
9.	Sinesi, D: 1 article (04/2009)
10.	Di Leo, E: 1 article (04/2009)

Related Diseases

1.	Asthma (Bronchial Asthma) 04/01/2002 - "Anti-asthmatic agents were classified according to their therapeutic role as follows: maintenance therapy for mild-moderate asthma (Mm); maintenance therapy for severe asthma (Ms); quick relief for mild attack (Qm) and quick relief for severe attack (Qs). " 03/01/1998 - "Increasing prevalence and severity of asthma worldwide encourage the development of new antiasthmatic drugs, alternative treatment regimens and improved formulations of established drugs. " 08/01/2008 - "Asthma and antiasthmatic drugs can influence patient's quality of life: this is why healthcare systems have recently focused on research studies about Health-Related Quality of Life (HRQL) in asthmatic patients. " 05/01/1992 - "To compound the practitioner's problem, the inability to perform human studies with asthma drugs has led the pharmaceutical companies to formally list precautions against the use of antiasthmatic drugs during pregnancy in the Physician's Desk Reference (PDR), a book which is available to the lay public and is often introduced in medicolegal suits as the primary reference for standard of care. " 01/01/1992 - "The first clinical trials of PAF antagonists in the treatment of resistant asthma have given results that are interesting but not superior to those obtained with the conventional anti-asthmatic drugs. " Order ALL the reference details at left...
2.	Respiratory Sounds (Crackle) 01/01/1994 - "The efficacy of the drug was evaluated according to respiratory symptom and medication scores, in which numerical values were assigned to various other antiasthmatic agents used to control wheezing. " 03/01/1994 - "Altogether 4.3% were woken more than once a week by wheezing, 13.1% had doctor diagnosed asthma, and 13.6% had been prescribed antiasthmatic drugs in the past year. " 09/01/1995 - "Two different definitions of asthma were adopted: 1) prevalence of asthma attack in the last 12 months; 2) prevalence of asthma attack or treatment with antiasthmatic drugs, or both wheezing apart from the common cold and wheezing with shortness of breath. " Order ALL the reference details at left...
3.	Cough 10/01/1991 - "Prescribing of decongestants, especially systemic, decreased during the study period whereas that of anti-asthmatics increased, partly due to the non-approved use of these drugs for common cough. " 11/01/2007 - "Children present 3.8-8 infective episodes per year with cough lasting, on average, 1-3 wk and 10% will still have cough after 4 wk. There is evidence of over-treatment of cough with antibiotics, anti-asthmatic drugs (in Italy) and symptomatic treatments, all with insufficient evidence of efficacy. " 01/01/2000 - "The improvement of mentioned cough indexes was absent in 17 patients who were treated by magnetotherapy too, but at the same time suffered from respiratory viral infection and in 22 patients treated only with climatotherapy and antiasthmatics. " 11/01/2006 - "The individual prescription of anti-asthmatics increased by 155% (p<0.001), the use of nasal preparations and drugs against cough decreased, and more of the antibiotics were penicillin V. In 0-1-y-olds, prescriptions halved, while they nearly doubled in schoolchildren (p<0.001). " 05/01/2004 - "MAIN RESULTS: The 10-day cumulative effect of a 10-microg/m(3) black smoke increase was significantly associated with a 6.2% (95% CI, 2.4-10.1%) increase in the sales of anti-asthmatics and bronchodilators and to a 9.2% (95% CI, 5.9-12.6%) increase in the sales of cough and cold preparation for children aged under 15 years. " Order ALL the reference details at left...
4.	Hypersensitivity (Allergy) 05/01/1994 - "The use of antiasthmatic agents in children before referral to a children's clinic for allergy was studied in two periods (1979-83 and 1988-91). " 01/01/1961 - "[Some remarks on the appearance of allergic reactions after the use of antiasthmatics.]" 09/01/2004 - "OBJECTIVES: The purpose of the present study was to determine the effects of representative antiasthmatic agents, including cysteinyl leukotriene (cysLT) 1 receptor antagonists, corticosteroid, and tacrolimus, on DCs in inducing allergy. " 11/01/1986 - "A new chemical compound, 11-oxo-11H-pyrido[2,1-b]quinazoline-2-carboxylic acid (Sm 857), known to inhibit the second stage type I allergy and endowed with antiasthmatic action, was investigated with regard to its effects on theophylline (TP) blood level in comparison with ketotifen and tranilast, antiasthmatics of the same therapeutic category as Sm 857, and tiaramide, an antiinflammatory agent. " Order ALL the reference details at left...
5.	Inflammation 09/01/2000 - "In the future, follow-up studies on bronchial responsiveness and airway inflammation, as well as controlled studies on both short- and long-term effects of antiasthmatic drugs in the athletes are needed." 04/01/2008 - "Lower airway fibroblasts may play a critical role in airway inflammation and remodelling, suggesting that they might represent an important target for the major anti-asthmatic drugs. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Steroids
2.	Nedocromil (Alocril)
3.	cysteinyl-leukotriene
4.	Thromboxane Receptors (Thromboxane Receptor)
5.	Tacrolimus (Prograf)
6.	Nasal Decongestants (Decongestants)
7.	leukotriene D4 receptor (cysteinyl leukotriene receptor)
8.	seratrodast
9.	minocromil
10.	ozagrel

Related Therapies and Procedures

1.	Therapeutics
2.	Climatotherapy
3.	Artificial Respiration (Mechanical Ventilation)
4.	Intravenous Infusions
5.	Cesarean Section (Caesarean Section)

blog comments powered by Disqus

TREATMENT OPTIONS
for Asthma,
Ranking and Evidence

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.

Free Updates for 1 Year
All 2936 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Evidence References
Sample PDF Report on Psoriasis >>

Price:

$8.50 USD & Delivery via PDF download
updates for 1 year

Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:

Two-clicks from Disease to Drug to Evidence: Drill down to full abstract
Enable Experts: Quickly identify key researchers and their publications
Enable FDA Link Generic: Two-clicks to FDA Products/Patents/Generics
Enable Export: All outcome statements and scores exportable to Excel/TSV for automated meta-analysis
Research Network: Explore drug and disease relationships visually
Enable Mobile Interface: Access from your cellphone, iPhone or PDA

Price:

$45.00 USD access via web interface
1 year subscription

Request Bulk Institution License Details >>